Roboclinic review

The underlying offer is a good one for somebody planning to hold small: one price at every dose, consultation and delivery included, no membership fee underneath, and — less commonly — an oral tablet priced beside the injection, so the needle-free route has an actual number rather than a promise. Where it becomes less straightforward is the presentation. Every price appears next to a higher struck-through figure, permanently, and nothing published says what that figure is or when the lower one expires. A markdown that never ends is not a discount; it is the price with decoration beside it, and its only effect is to make a standing rate look like a closing window. The same pattern repeats in the advertised saving on extended plans, which is quoted as a monthly figure without the extended plans themselves being priced anywhere — so a reader cannot check the arithmetic or work out what committing longer would actually cost them. No dose sits behind either price, though on a genuinely flat plan that matters less than it would elsewhere. Only semaglutide is named on the site.

Vs median

$10/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Price last updated

August 2026

Roboclinic dispenses through a Not named facility. No bloodwork is required before you start. A clinician review is included in the price.

The core offer is a good one for anyone planning to hold a small dose: one price at every dose, consult and delivery included, no membership fee sitting underneath, and — unusually — an oral tablet priced beside the injection so the needle-free route has a real number on it rather than a promise. Where it gets less straightforward is the presentation. Every price appears next to a higher struck-through figure, permanently, with nothing on the page saying what that figure is or when the lower one expires. A markdown that never ends is not a discount; it is the price with decoration beside it, and it makes the offer look like a limited chance when it is simply the rate. The same applies to the advertised saving on extended plans, which is quoted without the extended plans themselves being priced, so a reader cannot check the arithmetic or work out what committing longer actually costs. No dose sits behind either figure, though on a flat plan that matters less than it would elsewhere.

Every price sits beside a permanent struck-through figure that no one is charged.

• A saving on extended plans is advertised without those plans being priced.
• No dose is published behind either figure, and no pharmacy is named.

Roboclinic is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• Oral semaglutide (Rybelsus)
• What a flat price costs at a low dose
• The true annual cost of a plan